Related Experiment Video
Updated: May 1, 2026
Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Evaluation of methods of detecting cell reactive oxygen species production for drug screening and cell cycle studies
1John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Abstract:
Intracellular reactive oxygen species (ROS) production is essential to normal cell function. However, excessive ROS production causes oxidative damage and cell death. Many pharmacological compounds exert their effects on cell cycle progression by changing intracellular redox state and in many cases cause oxidative damage leading to drug cytotoxicity. Appropriate measurement of intracellular ROS levels during cell cycle progression is therefore crucial in understanding redox-regulation of cell function and drug toxicity and for the development of new drugs. However, due to the extremely short half-life of ROS, measuring the changes in intracellular ROS levels during a particular phase of cell cycle for drug intervention can be challenging. In this article, we have provided updated information on the rationale, the applications, the advantages and limitations of common methods for screening drug effects on intracellular ROS production linked to cell cycle study. Our aim is to facilitate biomedical scientists and researchers in the pharmaceutical industry in choosing or developing specific experimental regimens to suit their research needs.
Insights
Measuring intracellular reactive oxygen species (ROS) during the cell cycle is vital for understanding drug toxicity and cell function. This review aids researchers in selecting methods for studying ROS and drug effects on cell cycle progression.
Area of Science:
- Cell Biology
- Pharmacology
- Biochemistry
Background:
- Intracellular reactive oxygen species (ROS) are crucial for normal cell function but excessive production leads to oxidative damage and cell death.
- Pharmacological compounds can alter intracellular redox states, affecting cell cycle progression and potentially causing drug cytotoxicity through oxidative damage.
- Accurate measurement of intracellular ROS during cell cycle progression is essential for understanding redox regulation, drug toxicity, and developing new therapeutics.
Purpose of the Study:
- To provide updated information on methods for screening drug effects on intracellular ROS production in relation to cell cycle studies.
- To discuss the rationale, applications, advantages, and limitations of common ROS measurement techniques.
- To assist biomedical scientists and pharmaceutical researchers in selecting appropriate experimental methods.
Main Methods:
- Review of existing literature on intracellular ROS measurement techniques.
- Analysis of methods commonly used in conjunction with cell cycle analysis.
- Discussion of challenges related to the short half-life of ROS.
Main Results:
- The article consolidates information on various methods for assessing drug-induced changes in intracellular ROS.
- It highlights the importance of correlating ROS levels with specific cell cycle phases.
- The review addresses the practical considerations and limitations of current methodologies.
Conclusions:
- Effective measurement of intracellular ROS during cell cycle progression is critical for drug development and understanding cellular redox balance.
- Choosing the right methodology is key to accurately assessing drug effects on ROS production and cell cycle.
- This work aims to guide researchers in optimizing their experimental designs for studying ROS and drug cytotoxicity.
